Anju Software

Anju Software

Anju Software is a portfolio company of Valsoft, a Montreal-based acquirer of vertical market software businesses. Anju builds and sells clinical trial management, medical affairs, and data science tools to pharmaceutical companies, CROs, and medical device firms. The firm's flagship products—TrialMaster, IRMS MAX, and TA Scan—are used by 10 of the top 20 global biopharma companies. The company's strategy centers on developing a connected suite of life sciences software rather than individual point solutions. It targets the eClinical and medical affairs segments, where clients include large and mid-sized pharma companies as well as agencies. Anju's technology platform links disparate data sources to reduce complexity in drug and device discovery. The firm operates across North America and partners with global biopharma clients. Anju does not publicly disclose AUM, headcount, or investment deployment figures. The firm is structured as a controlled operating company within Valsoft, which provides capital and platform support. No recent operational events beyond product launches (Luminee eClinical suite, May 2025) have been reported in financial media. Anju's structural differentiator is its position as a vertical-market software rollup within Valsoft, rather than a standalone life sciences firm. This model allows the parent company to supply acquisition capital and operational infrastructure while Anju focuses on product development and customer retention. The governance relationship with Valsoft shapes both the firm's growth and its limited public disclosure.